Our team received a $250.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

I received a $1,500.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

I received a $1,500.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

Terrific abstracts to focus on if your interests lie in #bladdercancer or #kidneycancer. Thank you Gil Morgan, MD for your tireless efforts to bring us together to optimize #oncology education!

So proud of the work we’ve started and and presented at #ASCO24 by superstars 🌟Antonio Ocejo Ana S. Salazar, MD, MPHS University of Miami Internal Medicine Residency on #RCC in #Hispanic/#Latino patients at Sylvester Comprehensive Cancer Center. Some takeaways: 🎯Diagnosed younger (53% under 60 vs. 44% for non-Hispanic/Latino) 🎯Higher aggressive

Today we visited the new Kenneth C. Griffin Cancer Research Building, future home of our Sylvester Comprehensive Cancer Center Phase 1 Unit! Here we will continue bringing new treatments and hope for our cancer patients! Go Sylvester!

Enjoying amazing science & discussion at translational cancer #immunotherapy symposium Sylvester Comprehensive Cancer Center Beautiful campus, tremendous faculty & organization-congrats Miller Medicine! Even got pool side trumpet practice in! Society for Immunotherapy of Cancer #Checkpoints Party next week #SITC24-BE THERE!

Dr Marc Theoret from ⁦U.S. FDA⁩ discussing initiatives to enhance development of novel endpoints in oncology drug development, including immunotherapies! ⁦Sylvester Comprehensive Cancer Center⁩ 2nd TCO Symposium, Miami, Florida

Dr Damian Green, chief, Div Of Transplantation and Cellular Therapy ⁦Sylvester Comprehensive Cancer Center⁩ discussing mechanisms of immunotx resistance and strategies to overcome them, and bench to bedside strategies led by him and his group! ⁦C. Ola Landgren, M.D.⁩

Dr Antonio Iavarone, Deputy Director ⁦Sylvester Comprehensive Cancer Center⁩ discussing novel precision medicine approaches for high grade gliomas at the 2nd annual TCO Symposium!

CLEAR study biomarker analysis with Robert Motzer MD and friends is out in Annals of Oncology —thank you EIC Tom Powles for a flawless process! Lenvatinib + Pembrolizumab improved ORR/PFS vs. sunitinib in aRCC, consistent across PD-L1, gene expression, mutations, subtypes. No

The finding of no predictive biomarker underscores that there is more work to be done! Hats off to Toni Choueiri, MD Robert Motzer MD Camillo Porta Jaime Merchan et al for pushing for this biomarker work to be done.

Today was our Phase 1 holiday celebration! Proud to be part of this incredible, hard working team, bringing new treatments, and hope for our patients in South Florida and beyond! Thank you team! Happy holidays!

5/ And now Neeraj Agarwal, MD, FASCO with a practice-informing trial for #Belzutifan in #RCC. More is not always better! The efficacy of belzutifan was similar between the 120 mg dose and the 200 mg dose for previously treated #ccRCC. Annals of Oncology ESMO - Eur. Oncology annalsofoncology.org/article/S0923-…

Collaboration is key! Hear from top experts across disciplines as they tackle renal cell carcinoma treatment strategies. What’s your biggest question about RCC? Drop it below! #DSUIOnTheBeach25

Desai Sethi Urology Institute Dipen J Parekh, M.D. Pratik Kanabur Dr. Jihad Kaouk José A. Karam Mark L. Gonzalgo, MD, PhD, MBA UCLA Urology BCM Department of Urology Cleveland Clinic MD Anderson Cancer Center We had a great discussion on the surgical and medical oncology management of challenging RCC cases! UCLA, Cleveland Clinic, MD Anderson Cancer Center and Sylvester Comprehensive Cancer Center in one table!

This amounts to the most significant data leak in cyber history. Private individuals in the data business now have access to your Social Security information. This violates data privacy laws in every state. Hopefully, state AGs will file suit and pursue criminal charges.

Great opportunity for graduating fellows interested in early phase clinical research training! Fellows will work with and learn from a great team! Consider applying!

Scientists know how to have fun!! “The Checkpoints” live in Chicago!!! Good vibes and great music!

Join us for the 2025 Design and Management of Cancer #ClinicalTrials course! This 6-week course covers essential research concepts for designing and managing cancer clinical trials. Sign up now: Sylvester.org/ClinicalTrials…. 🔬 Mikkael A. Sekeres MD, MS @LatinaMD Ruben A. Mesa, MD Jon Trent, MD, PhD